Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to share the latest issue of touchREVIEWS in Ophthalmology, showcasing a diverse range of articles that highlight the innovation, interdisciplinary collaboration and continued advances driving progress in eye care today. We begin this issue with an important and under-explored topic, as Fatma et al. present an investigative review examining the potential association […]

Ahmad A Aref, AGS 2022: Head to Head Surgical Trials: Which Microinvasive Glaucoma Surgery? Show Me the Evidence

4 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 14th 2022

We were delighted to speak with Professor Ahmad Aref (University of Illinois College of Medicine, Chicago, IL) about the COMPARE study where the efficacy of different microinvasive glaucoma surgery (MiGS) devices were compared for reducing intraocular pressure and medications in glaucoma.

The presentation entitled ‘Head to Head Surgical Trials: Which MiGS? Show Me the Evidence’ was presented at the 2022 American Glaucoma Society Annual Meeting, March 03-06, 2022

Questions:

  1. What did we learn from the COMPARE study of two microinvasive glaucoma surgery (MiGS) devices?(00:21)
  2. What other head-to-head trials have been completed or are in progress?(03:37)

Disclosures: Ahmad Aref is a consultant for Nova Eye Medical and has received grant/research support from Allergan, Inc.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Filmed in coverage of the virtual AGS 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup